RB To Split OTC And Infant Nutrition As CEO Hits Reset Button

 
• By Tom Gallen

Reckitt Benckiser's new CEO Laxman Narasimhan has unveiled a turnaround plan which will see the company's OTC drugs and dietary supplements housed in a separate business to its infant nutrition products. RB is investing £2bn to get back on track after a couple of difficult years.

Hand man doing finances and calculate on desk about cost at home office.
• Source: Shutterstock

More from Strategy

More from Business